vMIP-II (1-21), a peptide sourced from viral macrophage inflammatory protein-II (vMIP-II), exhibits exclusive chemokine receptor antagonism by specifically engaging receptors implicated in immunological reactions. Its remarkable anti-inflammatory attributes make vMIP-II (1-21) a compelling candidate for biomedical investigations concerning the modulation of chemokine receptors across diverse pathological conditions, encompassing autoimmune maladies, inflammatory-linked malignancies, and viral afflictions.
CAT# | GR2184 |
CAS | 265650-93-9 |
M.F/Formula | C108H169N33O27S |
M.W/Mr. | 2425.84 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Ecallantide, sold under the trade name Kalbitor, is a plasma kallikrein inhibitor, consisting of sixty amino aci ...
PKC (19-36), a synthetic peptide of the pseudosubstrate domain of the kinase, is a selective inhibitor of prote ...
The 70-kDa heat shock protein (HSP70) contains three domains: the ATPase N-domain, which hydrolyses ATP, the sub ...
Tertiapin-Q (TPN-Q) is a small compact protein that contains twenty-one amino acids, which derived from bee veno ...
Long-term potentiation (LTP) is a persistent synaptic enhancement which is thought to be a substrate for memory. ...